Table 2.
Structures of protein receptors (PDB ID) for docking simulation
| No | Pathology of cancer cells | Drug target mechanisma | PDB ID |
|---|---|---|---|
| 1 | Avoiding immune destruction | Anti CTLA-4 monoclonal antibody | 4GCA |
| 2 | Replicative immortality | Telomerase inhibitor | 5DFM |
| 3 | Tumor-promoting inflammation | Selective anti-inflammatory drugs | 1CX2 |
| 4 | Invasion and metastasis | Hepatocyte growth factor/c-Met inhibitor | 4MXC |
| 5 | Angiogenesis | VEGFR signaling inhibitor | 3CP9 |
| 6 | Genome instability | PARP inhibitor | 5WRQ |
| 7 | Resisting cell death | Pro-apoptotic BH3 mimetic (inhibitor BCl-2) | 4C5D |
| 8 | Deregulating cell energetics | Aerobic glycolysis inhibitor | 4JNK |
| 9 | Sustaining proliferative signaling | EGFR inhibitor | 1M17 |
| 10 | Evading growth suppressors | CDK2 inhibitor | 2UZO |
| CDK6 inhibitor | 5L2I |
Note:
The 10-drug target mechanisms were selected according to the hallmarks of cancer, as described by Hanahan and Weinberg.26
Abbreviation: PDB ID, Protein Data Bank identity.